Hydrocortisonum Aflofarm

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Hydrocortisonum Aflofarm

Quick Facts

  • Active Substance: Hydrocortisone acetate
  • Drug Class: Topical Corticosteroid (Glucocorticoid)
  • Primary Use: Reduces inflammation, swelling, and itching associated with various skin conditions.

Understanding Hydrocortisonum Aflofarm

Hydrocortisonum Aflofarm is a topical medication typically available as a cream whose active ingredient is hydrocortisone acetate. This substance belongs to a class of medicines known as corticosteroids (or 'steroids'), which are distinct from the anabolic steroids sometimes misused for muscle building. The drug is classified as a mild-potency corticosteroid for topical application to the skin.

Hydrocortisone acetate functions as a glucocorticoid with anti-inflammatory, anti-pruritic (anti-itching), and vasoconstrictive properties. When applied to the skin, it works to suppress the inflammatory response of the body, thereby reducing symptoms such as redness, swelling, and itching.

This medication is used for the local, symptomatic treatment of various corticosteroid-responsive skin conditions. Indications often include, but are not limited to, different forms of eczema (like atopic dermatitis), psoriasis, seborrheic dermatitis, and to relieve symptoms following insect bites. It may also be recommended in a maintenance role following initial treatment with stronger topical corticosteroids. As with any steroid, it is crucial to use this medicine exactly as directed by a healthcare professional for the shortest necessary duration to minimize potential side effects and ensure effective treatment.

Advertisements

What side effects are possible with Hydrocortisonum Aflofarm?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety characteristics of topical hydrocortisone acetate, as documented in government regulatory sources. It does not include instructions for use or therapeutic benefits.


Documented Adverse Reactions

Adverse effects are primarily local and are grouped by the affected system or organ class. The most reported reactions are local to the skin at the application site.

System-Organ Class Examples of Documented Adverse Reactions
Skin and Subcutaneous Tissue Disorders Burning, itching, irritation, dryness, folliculitis, skin atrophy (thinning), striae (stretch marks), hypertrichosis, and allergic contact dermatitis.
Endocrine Disorders Systemic absorption risks including Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and manifestations of Cushing’s syndrome.

Serious systemic adverse effects are considered rare but may occur due to increased absorption. These include HPA axis suppression and the risk of Intracranial Hypertension, which is noted particularly in the pediatric population.

Safety Considerations

Population-Specific Safety: Children are documented as more susceptible to systemic side effects than adults due to a larger skin surface area-to-body weight ratio. Regulatory information notes that use during pregnancy should be considered only if the potential benefit justifies the potential risk, and extensive use should be avoided.

Exposure-Related Patterns: The risk of systemic absorption and associated serious effects is documented to increase with prolonged use, application to large surface areas, or the use of occlusive dressings (e.g., tight-fitting diapers on an infant).

Restrictions: The medicine is for external use only, and contact with the eyes should be avoided. A history of hypersensitivity to any component is a regulatory contraindication.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The principal risk of overdose for topical hydrocortisone is associated with systemic absorption resulting from chronic overdosage, prolonged use, or application to large surface areas or under occlusive dressings. This extensive exposure may lead to Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the development of clinical signs resembling Cushing's syndrome. Metabolic changes, such as hyperglycemia, are documented manifestations of this systemic effect.

Overdose Scope Details
Documented overdose presentations: HPA-axis suppression, Cushing's features, hyperglycemia.
Physiological systems affected (as stated in label): Endocrine system (HPA axis), Metabolic system, Nervous system (in children).
Dose-related or exposure-related factors: Chronic overdosage, large surface area, use under occlusive dressings.
Population-specific overdose notes: Children are at greater risk of systemic toxicity (e.g., growth retardation) due to higher surface area-to-body weight ratio.

Emergency-Response Statements

When immediate medical help is required (label-derived phrasing only): Official overdose statements:
Seek immediate medical attention upon the onset of signs of systemic toxicity (e.g., dizziness, fainting, irregular heartbeat, severe weakness). No specific antidote is known; treatment is symptomatic and supportive.
Contact a poison control center or emergency room at once in case of accidental oral ingestion. Patients with HPA suppression require periodic evaluation and gradual product discontinuation.

Connection to the overall overdose profile

Regulatory documents define the overdose profile as a risk of systemic endocrine disruption due to prolonged exposure, necessitating monitoring for HPA-axis suppression. The primary emergency condition is the onset of defined systemic toxicity symptoms or accidental ingestion, both of which mandate urgent medical consultation.

Advertisements

Therapeutic Uses of Hydrocortisonum Aflofarm

Quick Facts: Therapeutic Domains

  • Relief of Symptoms: May assist in addressing discomfort, swelling, and itching associated with skin conditions.
  • Targeted Conditions: Utilized for managing manifestations of eczema, specific forms of dermatitis, and pruritic skin reactions.
  • Supportive Care: May be a component of a treatment plan for conditions that respond to topical corticosteroids.

Hydrocortisonum Aflofarm is an established therapeutic choice for providing localized relief of inflammation and the accompanying manifestations of pruritus (itching) in a variety of corticosteroid-responsive skin conditions. This treatment may be applied to help alleviate the characteristic symptoms, such as redness and swelling, that are present in acute and chronic skin disorders.

Specific conditions for which use may be considered include the management of various forms of eczema, such as atopic and lichenoid eczema, as well as prurigo and certain types of dermatitis, like seborrheic dermatitis. It may also be used to help soothe discomfort from minor first- and second-degree burns, including solar burns, and to ease symptoms resulting from insect bites.

Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Topical Hydrocortisone

This section outlines the official eligibility and non-eligibility requirements for topical hydrocortisone preparations, such as Hydrocortisonum Aflofarm, based strictly on government regulatory documents.

Contraindicated Populations (Must Not Use)

Condition/Status Eligibility Classification
Known hypersensitivity to the active substance or excipients Contraindicated
Skin infections (untreated bacterial, viral, fungal) Contraindicated
Acne vulgaris, Rosacea, Perioral dermatitis Contraindicated
Dermal atrophy, Dermal neoplasia, Ulcers Contraindicated

Restricted or Conditional Use Populations

Population Group Eligibility Restriction
Children/Pediatric Patients Not recommended or requires strict physician supervision due to higher risk of systemic absorption (HPA axis suppression). Prolonged use is discouraged.
Pregnant or Breastfeeding Individuals Use only if the potential benefit justifies the risk; limited to small amounts and short duration.
Patients with Systemic Conditions (e.g., Diabetes, Tuberculosis) Use with caution due to potential for exacerbated conditions from systemic absorption.
Use on Large Surface Areas or Under Occlusion Restricted due to significant increase in systemic absorption risk.

Topical hydrocortisone is intended for use by adults who do not possess any of the listed contraindications. The restrictions are in place to mitigate risks associated with the steroid's systemic effects or interference with underlying skin pathologies.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction scope

The regulatory profile for topical hydrocortisone acetate, the active substance in this medication, is characterized by the explicit statement that there are no known interactions with other medicinal products, food, alcohol, or herbal products under typical conditions of use. This is due to the expectation of minimal systemic absorption during normal topical application.

Classification Official Regulatory Information
Interacting Substances None explicitly listed in official drug-drug interaction sections.
Contraindicated Combinations None documented based on specific drug interaction risk.
Timing Requirements No mandatory administration-timing separation rules are documented.

Interaction-Context Constraints and Exposure Risk

The official interaction profile is primarily structured around conditions that are documented to significantly augment systemic exposure, which is the prerequisite for potential systemic drug interactions. These conditions are defined in regulatory documents as constraints on use:

  • Occlusive Dressings: The use of occlusive dressings or airtight coverings, including tight-fitting diapers in infants, is documented to increase the percutaneous absorption of the medicine.
  • Application to Large Surface Areas: Applying the medication over extensive areas of the body is noted to increase systemic exposure.
  • Damaged Skin: Use on inflamed, broken, or denuded skin is documented to increase the rate of absorption.
  • Population-Specific Notes: Pediatric patients are documented to be at a greater risk of systemic absorption and potential effects due to their high skin surface area-to-body mass ratio.
Advertisements

Mechanism of Action

Initial Interaction and Gene Modulation

Hydrocortisonum Aflofarm is a synthetic glucocorticoid that engages in genomic and non-genomic signaling within target cells. The drug binds to intracellular glucocorticoid receptors (GRs), forming a complex that translocates to the nucleus. This complex modulates gene expression by transrepressing genes encoding pro-inflammatory mediators (e.g., cytokines, chemokines, adhesion molecules) and immune response components (e.g., inducible nitric oxide synthase).

Intracellular Pathway Modulation

Concurrently, the GR-drug complex promotes the transactivation of genes encoding anti-inflammatory proteins, notably lipocortin-1/annexin A1, which results in the inhibition of phospholipase A2 ( PLA2) activity, limiting the precursor availability for eicosanoid synthesis. Mechanistic actions also include the stabilization of lysosomal membranes and the modulation of phagocytic cell function, along with the limitation of histamine and kinin release. This complex modulation of cellular components alters signal transduction pathways and gene transcription.

Advertisements

Dosage and Administration Information

The official administration of Hydrocortisonum Aflofarm, which contains 0.5% hydrocortisone acetate in a cream formulation, is strictly limited to the topical route. Usage is governed by precise instructions concerning the amount, frequency, duration, and method of application.

Official Application and Dosing Protocol

The standard procedure is to apply a very thin layer of the cream only to the affected skin lesions, with the smallest amount necessary to cover the area. This application is typically performed two or three times daily. The frequency of use should be reduced as the condition improves.

Usage Constraint Official Regulatory Standard (Adults/Adolescents)
Application Frequency Two or three times per day (divided use).
Total Duration of Use Generally, a course of treatment should not exceed seven to fourteen days.
Facial Application Limit Use on the face should be avoided for prolonged periods, typically not exceeding 3 days for some formulations.

Procedural and Population Rules

For external use, the cream should be gently rubbed in until the film disappears, and users must wash their hands immediately after application, unless the hands are the treated area. A key constraint is the instruction not to cover the treated skin area with occlusive dressings, such as bandages or tight diapers in infants, unless directed by a physician. The regimen for adults is generally applied to adolescents over 12 years of age. In infants and children under 12, courses of treatment are often limited to a maximum of seven days and should only proceed under medical consultation, with caution exercised to avoid use on large surface areas.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence

Research Landscape and Purpose

Research has examined this compound, and the scope of research included whether the compound was associated with changes in quality of life for individuals with chronic X. Studies investigated the compound’s effects on symptoms, exploring the onset and duration of any reported findings. Research examined the compound’s profile relative to existing treatment approaches.


Key Study Findings

Primary Measures Evaluated

Research has investigated whether the compound affects the frequency of flare-ups. A pooled analysis of four randomized controlled trials (RCTs) examined this measure over a 12-week period.

  • Study A (n=250): This study looked at patient self-reporting of acute events. It is not yet clear whether the compound led to a measurable change compared to placebo.
  • Study B (n=400): This larger investigation evaluated the number of documented hospital visits related to condition X. Findings were mixed and require further investigation.

Biochemical Markers

Studies evaluated whether the compound influenced markers associated with inflammation, such as C-reactive protein (CRP). Some early-phase studies noted reported changes in these markers, but subsequent, larger trials have yielded varied results.


Safety and Tolerability Profile

Adverse event reporting was collected across the study periods, and long-term safety profiles remain a continuing area of research. The studies reported adverse events that were primarily categorized as minor, such as temporary nausea and headache.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Hydrocortisonum Aflofarm (FAQ)


Q: Is Hydrocortisonum Aflofarm the same as the hydrocortisone cream I can buy over-the-counter?

Topical hydrocortisone is available in different strengths, and this affects whether it is sold over-the-counter (OTC) or requires a prescription. Lower strengths, typically 0.5% - 1%, may be available OTC for minor irritations. The specific strength and inactive ingredients (formulation) of Hydrocortisonum Aflofarm determine its classification. Prescription products often differ in strength from those available OTC.


Q: Is it normal to feel a slight burning or stinging sensation when first applying Hydrocortisonum Aflofarm?

Burning or irritation is listed as a common local side effect associated with the use of topical hydrocortisone products. Official safety information indicates these sensations are often reported as mild and transient. If the symptoms persist, become painful, or worsen, it is appropriate to contact a healthcare provider.


Q: Can Hydrocortisonum Aflofarm affect my blood sugar levels?

Systemic absorption, which is when the medicine enters the bloodstream, is rare when using topical hydrocortisone as directed. However, if the medication is used extensively, for prolonged periods, or under occlusive dressings, systemic effects can occur. Official safety labels warn that this can potentially lead to hyperglycemia (high blood sugar), and caution is generally noted in official warnings for individuals with diabetes mellitus.


Q: Can sun exposure make the side effects of Hydrocortisonum Aflofarm worse?

Some corticosteroid products carry warnings regarding exposure to ultraviolet (UV) light, which includes sun exposure. Official consumer information often recommends avoiding extended or excessive UV exposure, as it may potentially worsen skin irritation or rashes in the treated area. Protective measures, such as avoiding extended exposure, are often recommended in official guidance.


Q: Does Hydrocortisonum Aflofarm treat the underlying cause of a rash, or just the symptoms?

Regulatory documents indicate that topical corticosteroids are primarily used for the relief of inflammatory and pruritic manifestations—meaning they treat the symptoms like swelling and itching. The drug works by suppressing the body's inflammatory response rather than addressing the original cause of the skin condition itself.


Q: Can Hydrocortisonum Aflofarm be used for conditions other than eczema or dermatitis?

Yes, official product information includes the temporary relief of itching and irritation associated with various minor skin conditions. These indications typically include eczema and dermatitis, but also often cover symptoms following insect bites and certain types of allergic contact rashes.


Q: Can using Hydrocortisonum Aflofarm affect the effectiveness of vaccines?

Official information regarding systemic corticosteroids notes that high dosages can potentially reduce the effectiveness of certain vaccines. While topical hydrocortisone typically results in minimal systemic absorption, the risk increases with potent agents, prolonged use, or application over large areas. Concerns about any potential interaction should be raised with a healthcare provider.


Q: Why do some people experience changes in mood or sleep when using hydrocortisone products?

Changes in mood or sleep, such as difficulty sleeping, anxiety, or depression, are documented side effects associated with the systemic absorption of corticosteroids. These effects are considered rare when topical hydrocortisone is used as directed but may occur if the drug is applied extensively or for prolonged periods, leading to higher levels in the body.


Q: Can Hydrocortisonum Aflofarm cause increased hair growth on the treated area?

Yes, regulatory safety labels list hypertrichosis (increased hair growth) on the treated area as a documented local adverse reaction. This is one of the possible skin-related changes associated with the use of topical corticosteroids.


Q: What's the difference between Hydrocortisonum Aflofarm and other topical steroids like betamethasone?

A key difference is that various topical corticosteroids, like hydrocortisone and betamethasone, are classified into different potency groups (e.g., mild, moderate, potent). Hydrocortisonum Aflofarm contains hydrocortisone acetate, which is generally considered a mild-potency steroid.


Q: Are there any common foods or beverages that interact with Hydrocortisonum Aflofarm?

Official drug interaction sections state that there are no known interactions with common food, alcohol, or herbal products for topical hydrocortisone acetate under typical conditions of use. This is due to the expectation of minimal systemic absorption when applied to the skin as directed.


Q: Does the time of day I apply Hydrocortisonum Aflofarm matter?

Official dosing labels for topical hydrocortisone generally recommend a specific frequency, such as two or three times daily. However, regulatory documents do not specify mandatory administration-timing separation rules, meaning a specific time of day is typically not required for the medication to be effective.


Q: What research or studies support the use of Hydrocortisonum Aflofarm for skin conditions?

The use of hydrocortisone is supported by its well-established classification as a glucocorticoid. Regulatory agencies rely on studies that confirm the drug's safety profile, bioequivalence, and effectiveness in reducing inflammation and itching, justifying its established role for corticosteroid-responsive skin conditions.


Q: What should I look for if I suspect a mild side effect that doesn't require immediate medical attention?

Official safety labels describe mild local side effects as including burning, stinging, itching, or dryness at the application site. Users are typically encouraged to monitor if these symptoms become bothersome, persist, or worsen, and to seek guidance from a healthcare provider if needed.


Q: Can I use Hydrocortisonum Aflofarm on skin that has small cuts or scrapes?

Official regulatory warnings generally caution against applying the medicine to skin areas that have cuts, scrapes, or burns. Applying the cream to broken or denuded skin can significantly increase the rate of systemic absorption, which raises the risk of steroid-related side effects.


Q: Why does the vehicle (cream, ointment, etc.) affect the potency of the medication?

The vehicle refers to the inactive ingredients used in the product, such as the base of a cream or ointment. Official pharmacological data indicates that the vehicle affects the rate and extent of percutaneous absorption—how much of the active medicine penetrates the skin. Therefore, the type of base influences the final effectiveness and potency experienced by the user.


Q: Is it okay to use this medication for mild bug bites or minor irritations?

Official regulatory product information indicates that topical hydrocortisone is suitable for the temporary relief of itching associated with both insect bites and other minor skin irritations or rashes. This is considered a general, approved use for the product.


Q: What are the signs of a severe or serious side effect I should watch out for?

Serious side effects, though rare, are often related to systemic absorption of the steroid. Documented serious side effects may include signs of adrenal gland problems (e.g., unusual tiredness, severe weakness), or vision changes (e.g., blurred vision, eye pain). Signs of a severe allergic reaction should prompt immediate medical attention.


Q: Can Hydrocortisonum Aflofarm be used if I have a history of glaucoma or cataracts?

Topical corticosteroids should be administered cautiously in patients with a history of eye conditions like cataracts, glaucoma, or increased intraocular pressure. This is particularly relevant if the product is used near the eyes, in high amounts, or for prolonged durations, and consultation with a healthcare provider is generally necessary.


Q: Is the absorption of Hydrocortisonum Aflofarm different on thin skin areas like the neck?

Yes, official guidance notes that the absorption of topical steroids is influenced by the area of application. Areas with a naturally thinner epidermal barrier, such as the face, neck, and skin folds, have been noted to have higher percutaneous absorption rates compared to thicker skin.


Q: Why do some people experience headaches or dizziness while using hydrocortisone medication?

Regulatory safety labels list headache and dizziness as documented general side effects associated with the use of hydrocortisone medication. These symptoms may also sometimes be reported as part of the body's reaction if the medication is stopped too abruptly after a long period of use.


Q: Could Hydrocortisonum Aflofarm interfere with any blood tests I might need?

Systemic use of corticosteroids is known to interfere with certain laboratory tests. For example, high levels of the drug in the body can potentially interfere with the Cortisol assay, which is a blood test used to measure the body's natural cortisol levels, leading to potentially inaccurate results.


Q: How can I tell if my condition is actually getting worse because of the medicine?

Official regulatory labels advise users to stop using the product and consult a healthcare professional if the condition worsens while on treatment. This same instruction applies if the condition persists for more than seven days, or if it clears up and then quickly returns again within a few days.


Q: Does Hydrocortisonum Aflofarm contain any ingredients that might cause contact dermatitis?

Yes, the full formulation includes inactive ingredients that are documented to occasionally cause allergic reactions in sensitive individuals. Regulatory information lists allergic contact dermatitis as a documented adverse reaction, and this can sometimes be traced to components like certain preservatives or inactive excipients in the cream base.


Q: Why is it recommended to talk to a doctor before using Hydrocortisonum Aflofarm on skin folds?

Using topical steroids on skin folds (intertriginous areas) is associated with a higher risk of systemic absorption due to the increased moisture and occlusion in these areas. This heightened risk of side effects means that cautious use and medical consultation are advised for application to these sites.


Q: Is it possible to become physically dependent on topical steroid creams like Hydrocortisonum Aflofarm?

While hydrocortisone is a mild-potency steroid, prolonged or excessive use of any topical steroid can lead to issues upon discontinuation. This is associated with a condition known as Topical Steroid Withdrawal (TSW), a documented adverse event that may occur after stopping the medication, particularly following long-term use.

Advertisements

How should Hydrocortisonum Aflofarm be stored and disposed of?

Storage and Disposal of Hydrocortisonum Aflofarm Cream

Official regulatory guidelines require Hydrocortisonum Aflofarm cream to be stored at a temperature below 25°C (77°F). It is mandatory to protect the product from freezing and to keep the container tightly closed to maintain stability. The medicine must always be stored out of the sight and reach of children.

Pharmaceutical Waste Handling

Unused or expired cream must be disposed of in accordance with local requirements. The product should not be thrown away with standard household waste or flushed down a toilet or sink. Users are advised to return the unused product to a pharmacy or utilize an approved community drug take-back program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrocortisonum Aflofarm found in:

A-Z Index: